Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Higher Dose 17-OHPC in Obese Women
NCT03433040Phase 3Completed
- Sponsor
- University of South Florida
- Start
- Aug 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxyprogesterone caproate in preterm birth, sponsored by University of South Florida. Started Aug 2017; status: completed.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT03433040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03433040.